首页 > 抗体蛋白 > 抗体
APC/Cyanine7 anti-mouse CD3 Antibody
产品名称:
APC/Cyanine7 anti-mouse CD3 Antibody
产品类别:
抗体
产品编号:
100221
产品应用:
100221
[价格]
规格 价格 库存
25µg ¥ 1260 1

产品详情

Product Details

Verified Reactivity
Mouse
Antibody Type
Monoclonal
Host Species
Rat
Immunogen
γδTCR-positive T-T hybridoma D1
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation
The antibody was purified by affinity chromatography, and conjugated with APC/Cyanine7 under optimal conditions.
Concentration
0.2 mg/ml
Storage & Handling
The antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Application

FC - Quality tested

Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is =0.25 ?g per million cells in 100 ?l volume. It is recommended that the reagent be titrated for optimal performance for each application.

Excitation Laser
Red Laser (633 nm)
Application Notes

Additional reported application (for relevant formats) include: spatial biology (IBEX)1,2.

Additional Product Notes

BioLegend is in the process of converting the name APC/Cy7 to APC/Cyanine7. The dye molecule remains the same, so you should expect the same quality and performance from our APC/Cyanine7 products. Please contact Technical Service if you have any questions.

Application References

(PubMed link indicates BioLegend citation)
  1. Radtke?AJ,?et al.?2020.?Proc Natl Acad Sci U S A.?117:33455-65. (SB)?PubMed
  2. Radtke?AJ,?et al.?2022.?Nat Protoc.?17:378-401. (SB)?PubMed
Product Citations
  1. Chung Y, et al. 2014. J Vis Exp. 89: 51660. PubMed
  2. Sun L, et al. 2021. Cancer Cell. :. PubMed
  3. Mackel JJ, et al. 2022. Front Cell Infect Microbiol. 12:974175. PubMed
  4. Israelow B, et al. 2020. bioRxiv. . PubMed
  5. Marco Barros R, et al. 2016. Cell. 167: 203-218. PubMed
  6. Shimizu K, et al. 2020. Molecular Cell. 77(5):937-950.e6.. PubMed
  7. Viny AD, et al. 2019. Cell Stem Cell. 25:682. PubMed
  8. Alissafi T, et al. 2018. J Clin Invest. 128:3840. PubMed
  9. Ferrere G, et al. 2021. JCI Insight. 6:. PubMed
  10. Durgeau A, et al. 2018. Nat Commun. 9:5097. PubMed
  11. Silver AC, et al. 2018. Heliyon. 4:e00579. PubMed
  12. Marques RM, et al. 2021. Cell Death Differ. 28:3140. PubMed
  13. Turner JA, et al. 2020. Immunity. 53:1202. PubMed
  14. Chen S, et al. 2022. Cancer Discov. :. PubMed
  15. Coleby R, et al. 2021. Clin Exp Rheumatol. :39. PubMed
  16. Zheng H, et al. 2021. Frontiers in Cell and Developmental Biology. 9:641527. PubMed
  17. Zhou Y, et al. 2016. Acta Pharmacol Sin. 10.1038/aps.2016.102. PubMed
  18. Haertel E, et al. 2018. Eur J Immunol. 48:1001. PubMed
  19. Choi H et al. 2019. Cell Rep. 27(3):806-819 . PubMed
  20. Tordesillas L, et al. 2018. Nat Commun. 9:5238. PubMed
  21. Diao L, et al. 2022. iScience. 25:105511. PubMed
  22. Tirado-Gonzalez I, et al. 2021. Cancer Discov. 11:2924. PubMed
  23. Herman JD, et al. 2021. Nat Commun. 12:6853. PubMed
  24. Tilstam PV, et al. 2021. J Clin Invest. 131:. PubMed
  25. Ma C, et al. 2021. Signal Transduct Target Ther. 6:353. PubMed
  26. Leimkühler NB, et al. 2020. Cell Stem Cell. 28:637. PubMed
  27. Mathews J, et al. 2014. PLoS One. 9:97707. PubMed
  28. Shi L, et al. 2021. Immunity. . PubMed
  29. Rafiq S, et al. 2018. Nat Biotechnol. 36:847. PubMed
  30. Inoue D, et al. 2021. Nat Genet. 53:707. PubMed
  31. Chung H, et al. 2021. Immune Netw. 21:e28. PubMed
  32. Wang Z, et al. 2020. Autophagy. 1:. PubMed
  33. Spees A, et al. 2014. Infect Immun . 82:1692. PubMed
  34. Yoshimi A, et al. 2019. Nature. 574:273. PubMed
  35. Super M, et al. 2021. Nat Biomed Eng. Online ahead of print. PubMed
  36. Kunimoto H, et al. 2018. Cancer Cell. 33:44. PubMed
  37. Wei JL, et al. 2021. J Immunother Cancer. 9: . PubMed
  38. Han JP, et al. 2022. Sci Adv. 8:eabj6901. PubMed
  39. Zhao F, et al. 2022. Front Immunol. 13:873720. PubMed
  40. Pandey V, et al. 2021. eLife. 0.416666666666667. PubMed
  41. Kleppe M et al. 2018. Cancer cell. 33(1):29-43 . PubMed
  42. Katsinas N, et al. 2022. J Clin Med. 11:. PubMed
  43. Xue L, et al. 2021. BMC Cancer. 21:1134. PubMed
  44. Zhang B, et al. 2021. Nat Biomed Eng. 5:1288. PubMed
  45. Adane B, et al. 2019. Cell Rep. 27:238. PubMed
  46. Rashidi M, et al. 2019. J Immunol. 203:736. PubMed
  47. Schadt L, et al. 2020. Cell Reports. 29(5):1236-1248.e7.. PubMed
  48. Socodato R, et al. 2020. Sci Signal. 13: . PubMed
  49. Liu X, et al. 2022. Nat Cancer. :. PubMed
  50. Grune J, et al. 2022. Nat Cardiovasc Res. 1:649. PubMed
  51. Harb H, et al. 2021. Immunity. 54(6):1186-1199.e7. PubMed
  52. Habib S, et al. 2018. Infect Immun. 86:e00019. PubMed
  53. Rohner L, et al. 2020. Sci Rep. 0.570833333. PubMed
  54. Alameh MG, et al. 2021. Immunity. 54:2877. PubMed
  55. Li X, et al. 2020. Nat Commun. 4.877777778. PubMed
  56. Voss M, et al. 2015. Am J Physiol Lung Cell Mol Physiol. 309: L188 - L195. PubMed
  57. Lang V, et al. 2021. Elife. 10:. PubMed
  58. Jandke A, et al. 2020. Nat Commun. 3.075694444. PubMed
  59. Zhu W, et al. 2019. FASEB J. 33:5208. PubMed
  60. Fischer FA, et al. 2021. Proc Natl Acad Sci U S A. 118:. PubMed
  61. Robles-Oteiza C, et al. 2021. Dis Model Mech. 14:. PubMed
  62. Li J, et al. 2022. Nat Commun. 13:4032. PubMed
  63. Revathikumar P, et al. 2018. PLoS One. 13:e0193210. PubMed
  64. Zhang S, et al. 2022. Nat Commun. 13:4744. PubMed
  65. Kwok T, et al. 2022. Front Aging. 3:838943. PubMed
  66. Miyauchi E, et al. 2020. Nature. 585:102. PubMed
  67. Bellomo A, et al. 2020. Immunity. 53(1):127-142.e7. PubMed
  68. Teater M, et al. 2018. Nat Commun. 9:222. PubMed
  69. Draijer C, et al. 2018. Sci Rep. 8:5105. PubMed
  70. Yin S et al. 2019. Cancer cell. 35(2):283-296 . PubMed
  71. Sanchez HN, et al. 2020. Nat Commun. 0.5. PubMed
  72. Dhar P, et al. 2021. Commun Biol. 4:905. PubMed
  73. Do-Thi VA, et al. 2021. Cancers (Basel). 13:. PubMed
  74. Chen C, et al. 2020. Cell Rep. 2136:30. PubMed
  75. Bagati A, et al. 2020. Cancer Cell. 39(1):54-67.e9. PubMed
  76. Israelow B, et al. 2020. J Exp Med. 217:00:00. PubMed
  77. Clemente–Casares X, et al. 2017. Immunity. 47:974. PubMed
  78. Kim MY, et al. 2022. Nat Commun. 13:3296. PubMed
  79. Jie Z, et al. 2014. J Immunol. 192:3289. PubMed
  80. Szodoray P, et al. 2021. Cell Reports. 36(6):109525. PubMed
  81. Dokoshi T, et al. 2020. Cell Rep. 30:61. PubMed
  82. Chao JL, et al. 2021. Cell Rep Med. 2:100399. PubMed
  83. Rouse MD, et al. 2020. Front Microbiol. 11:414. PubMed
  84. Katzmarski N, et al. 2021. Nat Immunol. 22:1382. PubMed
  85. Sharma R, et al. 2021. J Neuroinflammation. 72:18. PubMed
  86. Siolas D, et al. 2021. Cell Reports. 36(8):109578. PubMed
  87. Hildreth AD, et al. 2020. STAR Protoc. 1:100113. PubMed
  88. Wen J, et al. 2015. J Pharmacol Sci. 128: 116-124. PubMed
  89. Luo H, et al. 2019. Cell Rep. 26:945. PubMed
  90. Li C, et al. 2021. Chem Biol Drug Des. 97:1151. PubMed
  91. Sheng D, et al. 2022. J Immunother Cancer. 10:. PubMed
  92. Kojima T, et al. 2016. Sci Rep. 6:36457. PubMed
  93. Wang K, et al. 2021. Nat Commun. 12:4558. PubMed
  94. Rodrigues KA, et al. 2021. Sci Adv. 7:eabj6538. PubMed
  95. Nakazawa S, et al. 2020. Sci Rep. 10:14559. PubMed
RRID
AB_2057374 (BioLegend Cat. No. 100221) AB_2242784 (BioLegend Cat. No. 100222)

Antigen Details

Structure
Ig superfamily, CD3/TCR, 20 kD
Distribution

Thymocytes (differentiation dependent), mature T cells, NK-T cells

Function
Antigen recognition, TCR signal transduction, T cell activation
Ligand/Receptor
Peptide antigen/MHC-complex
Antigen References

1. Barclay A, et al. 1997. The Leukocyte Antigen FactsBook Academic Press.
2. Davis MM. 1990. Annu. Rev. Biochem. 59:475.
3. Weiss A, et al. 1994. Cell 76:263.

Gene ID
12502 View all products for this Gene ID
UniProt
View information about CD3 on UniProt.org

联系我们

TEL:021-34661275  点击拨打热线